{
  "DOI": "10.1007/s12687-024-00705-y",
  "ISSN": [
    "1868-6001"
  ],
  "URL": "http://dx.doi.org/10.1007/s12687-024-00705-y",
  "alternative-id": [
    "705"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "20 January 2024"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "28 March 2024"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "8 April 2024"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Ethics approval",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "This study received ethical approval from the Hamilton Integrated Research Ethics Board (HiREB) at McMaster University (#15351); informed consent was documented for all participants."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "The authors declare that they have no conflict of interest."
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0001-6007-7825",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Cernat",
      "given": "Alexandra",
      "sequence": "first"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-5974-9361",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Samaan",
      "given": "Zainab",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-2907-2783",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Abelson",
      "given": "Julia",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0009-0002-3162-4871",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Ramdyal",
      "given": "Amanada",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Shaikh",
      "given": "Hadia",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-7347-6259",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Vanstone",
      "given": "Meredith",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Journal of Community Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2024,
        4,
        8
      ]
    ],
    "date-time": "2024-04-08T14:02:12Z",
    "timestamp": 1712584932000
  },
  "deposited": {
    "date-parts": [
      [
        2024,
        4,
        8
      ]
    ],
    "date-time": "2024-04-08T15:06:30Z",
    "timestamp": 1712588790000
  },
  "funder": [
    {
      "DOI": "10.13039/501100000024",
      "award": [
        "Vanier Canada Graduate Scholarship"
      ],
      "doi-asserted-by": "publisher",
      "name": "Canadian Institutes of Health Research"
    },
    {
      "DOI": "10.13039/100009776",
      "award": [
        "Department of Family Medicine Pilot Project Grant"
      ],
      "doi-asserted-by": "publisher",
      "name": "McMaster University"
    },
    {
      "DOI": "10.13039/100007461",
      "doi-asserted-by": "publisher",
      "name": "Fondation Brocher"
    },
    {
      "DOI": "10.13039/501100001804",
      "award": [
        "Ethical Complexity in Primary Care"
      ],
      "doi-asserted-by": "publisher",
      "name": "Canada Research Chairs"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        9
      ]
    ],
    "date-time": "2024-04-09T00:32:32Z",
    "timestamp": 1712622752511
  },
  "is-referenced-by-count": 0,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1868-6001"
    }
  ],
  "issued": {
    "date-parts": [
      [
        2024,
        4,
        8
      ]
    ]
  },
  "language": "en",
  "license": [
    {
      "URL": "https://www.springernature.com/gp/researchers/text-and-data-mining",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2024,
            4,
            8
          ]
        ],
        "date-time": "2024-04-08T00:00:00Z",
        "timestamp": 1712534400000
      }
    },
    {
      "URL": "https://www.springernature.com/gp/researchers/text-and-data-mining",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2024,
            4,
            8
          ]
        ],
        "date-time": "2024-04-08T00:00:00Z",
        "timestamp": 1712534400000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s12687-024-00705-y.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1007/s12687-024-00705-y/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s12687-024-00705-y.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2024,
        4,
        8
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2024,
        4,
        8
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.2147/ndt.S312966",
      "author": "S Aboelbaha",
      "doi-asserted-by": "publisher",
      "first-page": "2397",
      "journal-title": "Neuropsychiatr Dis Treat",
      "key": "705_CR1",
      "unstructured": "Aboelbaha S, Zolezzi M, Elewa H (2021) Effect of pharmacogenetic-based decision support tools in improving depression outcomes: A systematic review. Neuropsychiatr Dis Treat 17:2397–2419. https://doi.org/10.2147/ndt.S312966",
      "volume": "17",
      "year": "2021"
    },
    {
      "DOI": "10.1177/0706743720904820",
      "author": "A Al Maruf",
      "doi-asserted-by": "publisher",
      "first-page": "521",
      "issue": "8",
      "journal-title": "Can J Psychiatry",
      "key": "705_CR2",
      "unstructured": "Al Maruf A, Fan M, Arnold PD, Muller DJ, Aitchison KJ, Bousman CA (2020) Pharmacogenetic testing options relevant to psychiatry in Canada. Can J Psychiatry 65(8):521–530. https://doi.org/10.1177/0706743720904820",
      "volume": "65",
      "year": "2020"
    },
    {
      "DOI": "10.3390/jpm12030425",
      "doi-asserted-by": "publisher",
      "key": "705_CR3",
      "unstructured": "Allen JD, Pittenger AL, Bishop JR (2022) A scoping review of attitudes and experiences with pharmacogenomic testing among patients and the general public: Implications for patient counseling. J Pers Med 12(3). https://doi.org/10.3390/jpm12030425"
    },
    {
      "DOI": "10.3390/jpm12122046",
      "doi-asserted-by": "crossref",
      "key": "705_CR4",
      "unstructured": "Bagautdinova D, Lteif C, Eddy E, Terrell J, Fisher CL, Duarte JD (2022) Patients’ perspectives of factors that influence pharmacogenetic testing uptake: Enhancing patient counseling and results dissemination. Journal of Personalized Medicine 12(12): 2046. https://www.mdpi.com/2075-4426/12/12/2046"
    },
    {
      "DOI": "10.1016/j.sapharm.2020.06.022",
      "author": "D Bright",
      "doi-asserted-by": "publisher",
      "first-page": "744",
      "issue": "4",
      "journal-title": "Res Social Adm Pharm",
      "key": "705_CR5",
      "unstructured": "Bright D, Worley M, Porter BL (2021) Patient perceptions of pharmacogenomic testing in the community pharmacy setting. Res Social Adm Pharm 17(4):744–749. https://doi.org/10.1016/j.sapharm.2020.06.022",
      "volume": "17",
      "year": "2021"
    },
    {
      "DOI": "10.1002/cpt.2748",
      "author": "LC Brown",
      "doi-asserted-by": "publisher",
      "first-page": "1303",
      "issue": "6",
      "journal-title": "Controlled Clinical Trials Clin Pharmacol Ther",
      "key": "705_CR6",
      "unstructured": "Brown LC, Stanton JD, Bharthi K, Maruf AA, Müller DJ, Bousman CA (2022) Pharmacogenomic testing and depressive symptom remission: A systematic review and meta-analysis of prospective. Controlled Clinical Trials Clin Pharmacol Ther 112(6):1303–1317. https://doi.org/10.1002/cpt.2748",
      "volume": "112",
      "year": "2022"
    },
    {
      "DOI": "10.1177/1049732320945303",
      "author": "R Burgess",
      "doi-asserted-by": "publisher",
      "first-page": "1941",
      "issue": "12",
      "journal-title": "Qual Health Res",
      "key": "705_CR7",
      "unstructured": "Burgess R, Cernat A, Little L, Vanstone M (2020) Implementing publicly funded noninvasive prenatal testing for fetal aneuploidy in Ontario, Canada: Clinician Experiences With a Disruptive Technology. Qual Health Res 30(12):1941–1952. https://doi.org/10.1177/1049732320945303",
      "volume": "30",
      "year": "2020"
    },
    {
      "key": "705_CR8",
      "unstructured": "CADTH (2020) Pharmacogenomic testing for medication selection: A rapid qualitative review. https://www.cadth.ca/sites/default/files/rr/2020/RC1246%20PxGx%20Qualitative%20FINAL.pdf. Accessed Jan 2024"
    },
    {
      "key": "705_CR9",
      "unstructured": "CADTH (2021) Pharmacogenomic testing in depression: a 2021 update. Available from: https://www.cadth.ca/sites/default/files/pdf/htis/2022/RC1403%20RxGx%20testing%20depression%20update%20Final.pdf. Accessed Jan 2024"
    },
    {
      "key": "705_CR10",
      "unstructured": "CADTH (2023) An overview of pharmacogenomic testing for psychiatric disorders. https://www.cadth.ca/sites/default/files/pdf/htis/2023/EH0115%20Pharmacogenomic%20Testing%20for%20Psychiatric%20Disorders.pdf. Accessed Jan 2024"
    },
    {
      "DOI": "10.1177/0706743716660034",
      "doi-asserted-by": "publisher",
      "key": "705_CR11",
      "unstructured": "CANMAT (2016) CANMAT 2016 clinical guidelines for the management of adults with major depressive disorder. Canadian J Psych 61(9). https://doi.org/10.1177/0706743716660034"
    },
    {
      "key": "705_CR12",
      "unstructured": "Clinical Pharmacogenetics Implementation Consortium (CPIC) (2023) Genes-drugs. https://cpicpgx.org/genes-drugs/. Accessed 30 Mar 2024"
    },
    {
      "DOI": "10.1111/j.1365-2648.2007.04569.x",
      "author": "S Elo",
      "doi-asserted-by": "publisher",
      "first-page": "107",
      "issue": "1",
      "journal-title": "J Adv Nursing",
      "key": "705_CR13",
      "unstructured": "Elo S, Kyngäs H (2008) The qualitative content analysis process. J Adv Nursing 62(1):107–115. https://doi.org/10.1111/j.1365-2648.2007.04569.x",
      "volume": "62",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.pnpbp.2018.05.007",
      "author": "C Fabbri",
      "doi-asserted-by": "publisher",
      "first-page": "36",
      "journal-title": "Prog Neuropsychopharmacol Biol Psychiatry",
      "key": "705_CR14",
      "unstructured": "Fabbri C, Zohar J, Serretti A (2018) Pharmacogenetic tests to guide drug treatment in depression: Comparison of the available testing kits and clinical trials. Prog Neuropsychopharmacol Biol Psychiatry 86:36–44. https://doi.org/10.1016/j.pnpbp.2018.05.007",
      "volume": "86",
      "year": "2018"
    },
    {
      "DOI": "10.2217/pgs-2019-0004",
      "author": "MP Frigon",
      "doi-asserted-by": "publisher",
      "first-page": "589",
      "issue": "8",
      "journal-title": "Pharmacogenomics",
      "key": "705_CR15",
      "unstructured": "Frigon MP, Blackburn ME, Dubois-Bouchard C, Gagnon AL, Tardif S, Tremblay K (2019) Pharmacogenetic testing in primary care practice: opinions of physicians, pharmacists and patients. Pharmacogenomics 20(8):589–598. https://doi.org/10.2217/pgs-2019-0004",
      "volume": "20",
      "year": "2019"
    },
    {
      "DOI": "10.7326/0003-4819-155-11-201112060-00009",
      "doi-asserted-by": "publisher",
      "key": "705_CR16",
      "unstructured": "Gartlehner G, Hansen RA, Morgan LC, Thaler K, Lux L, Van Noord M, ... Lohr KN (2011) Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder. Ann Intern Med 155(11): 772–785. https://doi.org/10.7326/0003-4819-155-11-201112060-00009"
    },
    {
      "DOI": "10.1503/cmaj.221785",
      "doi-asserted-by": "publisher",
      "key": "705_CR17",
      "unstructured": "Ghanbarian S, Wong GWK, Bunka M, Edwards L, Cressman S, Conte T, ... Bryan S (2023) Cost-effectiveness of pharmacogenomic-guided treatment for major depression. Cmaj 195(44): E1499-e1508. https://doi.org/10.1503/cmaj.221785"
    },
    {
      "DOI": "10.1016/j.jpsychires.2019.01.003",
      "doi-asserted-by": "publisher",
      "key": "705_CR18",
      "unstructured": "Greden JF, Parikh SV, Rothschild AJ, Thase ME, Dunlop BW, DeBattista C, ... Dechairo B (2019) Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study. J Psychiatr Res 111:59–67. https://doi.org/10.1016/j.jpsychires.2019.01.003"
    },
    {
      "DOI": "10.1097/01.gim.0000227935.26763.c6",
      "author": "SD Grosse",
      "doi-asserted-by": "publisher",
      "first-page": "448",
      "issue": "7",
      "journal-title": "Genet Med",
      "key": "705_CR19",
      "unstructured": "Grosse SD, Khoury MJ (2006) What is the clinical utility of genetic testing? Genet Med 8(7):448–450. https://doi.org/10.1097/01.gim.0000227935.26763.c6",
      "volume": "8",
      "year": "2006"
    },
    {
      "key": "705_CR20",
      "unstructured": "Hayes Inc (2016) Pharmacogenomic testing for selected conditions: a health technology assessment prepared for the Washington State Healthcare Authority. https://www.hca.wa.gov/assets/program/pharmacogenomics-final-rpt-20161209.pdf. Accessed Jan 2024"
    },
    {
      "DOI": "10.2217/pgs-2021-0032",
      "author": "J Hayward",
      "doi-asserted-by": "publisher",
      "first-page": "761",
      "issue": "12",
      "journal-title": "Pharmacogenomics",
      "key": "705_CR21",
      "unstructured": "Hayward J, McDermott J, Qureshi N, Newman W (2021) Pharmacogenomic testing to support prescribing in primary care: a structured review of implementation models. Pharmacogenomics 22(12):761–776. https://doi.org/10.2217/pgs-2021-0032",
      "volume": "22",
      "year": "2021"
    },
    {
      "DOI": "10.3390/jpm9020025",
      "doi-asserted-by": "publisher",
      "key": "705_CR22",
      "unstructured": "Hendricks-Sturrup RM, Lu CY (2019) Direct-to-consumer genetic testing data privacy: Key concerns and recommendations based on consumer perspectives. J Pers Med 9(2). https://doi.org/10.3390/jpm9020025"
    },
    {
      "DOI": "10.1016/j.socscimed.2021.114523",
      "author": "M Hennink",
      "doi-asserted-by": "publisher",
      "journal-title": "Soc Sci Med",
      "key": "705_CR23",
      "unstructured": "Hennink M, Kaiser BN (2022) Sample sizes for saturation in qualitative research: A systematic review of empirical tests. Soc Sci Med 292:114523. https://doi.org/10.1016/j.socscimed.2021.114523",
      "volume": "292",
      "year": "2022"
    },
    {
      "DOI": "10.1016/j.jpsychires.2017.09.002",
      "doi-asserted-by": "publisher",
      "key": "705_CR24",
      "unstructured": "Herbert D, Neves-Pereira M, Baidya R, Cheema S, Groleau S, Shahmirian A, ... Kennedy JL (2018) Genetic testing as a supporting tool in prescribing psychiatric medication: Design and protocol of the IMPACT study. J Psychiatr Res 96:265–272. https://doi.org/10.1016/j.jpsychires.2017.09.002"
    },
    {
      "DOI": "10.1002/cpt.1611",
      "author": "RB Kim",
      "doi-asserted-by": "publisher",
      "first-page": "933",
      "issue": "5",
      "journal-title": "Clin Pharmacol Therapeutics",
      "key": "705_CR25",
      "unstructured": "Kim RB (2019) Precision medicine: Lessons learned from implementation of a pharmacogenetics-based patient care program in a real-world setting. Clin Pharmacol Therapeutics 106(5):933–935. https://doi.org/10.1002/cpt.1611",
      "volume": "106",
      "year": "2019"
    },
    {
      "DOI": "10.1097/fpc.0000000000000275",
      "author": "YM Lee",
      "doi-asserted-by": "publisher",
      "first-page": "179",
      "issue": "5",
      "journal-title": "Pharmacogenet Genomics",
      "key": "705_CR26",
      "unstructured": "Lee YM, McKillip RP, Borden BA, Klammer CE, Ratain MJ, O’Donnell PH (2017) Assessment of patient perceptions of genomic testing to inform pharmacogenomic implementation. Pharmacogenet Genomics 27(5):179–189. https://doi.org/10.1097/fpc.0000000000000275",
      "volume": "27",
      "year": "2017"
    },
    {
      "DOI": "10.2217/pgs-2017-0191",
      "doi-asserted-by": "publisher",
      "key": "705_CR27",
      "unstructured": "Lemke AA, Hulick PJ, Wake DT, Wang C, Sereika AW, Yu KD, ... Dunnenberger HM (2018) Patient perspectives following pharmacogenomics results disclosure in an integrated health system. Pharmacogenomics 19(4):321–331. https://doi.org/10.2217/pgs-2017-0191"
    },
    {
      "DOI": "10.1055/a-1183-5029",
      "author": "I Liko",
      "doi-asserted-by": "publisher",
      "first-page": "256",
      "issue": "6",
      "journal-title": "Pharmacopsychiatry",
      "key": "705_CR28",
      "unstructured": "Liko I, Lai E, Griffin RJ, Aquilante CL, Lee YM (2020) Patients’ perspectives on psychiatric pharmacogenetic testing. Pharmacopsychiatry 53(6):256–261. https://doi.org/10.1055/a-1183-5029",
      "volume": "53",
      "year": "2020"
    },
    {
      "DOI": "10.1370/afm.1687",
      "doi-asserted-by": "publisher",
      "key": "705_CR29",
      "unstructured": "Linde K, Kriston L, Rücker G, Jamil S, Schumann I, Meissner K, ... Schneider A (2015) Efficacy and acceptability of pharmacological treatments for depressive disorders in primary care: systematic review and network meta-analysis. Ann Fam Med 13(1):69–79. https://doi.org/10.1370/afm.1687"
    },
    {
      "DOI": "10.1111/j.1749-6632.1993.tb26351.x",
      "author": "J Lomas",
      "doi-asserted-by": "publisher",
      "first-page": "226",
      "journal-title": "Ann N Y Acad Sci",
      "key": "705_CR30",
      "unstructured": "Lomas J (1993) Diffusion, dissemination, and implementation: who should do what? Ann N Y Acad Sci 703:226–235. https://doi.org/10.1111/j.1749-6632.1993.tb26351.x. (discussion 235–227)",
      "volume": "703",
      "year": "1993"
    },
    {
      "DOI": "10.1038/clpt.2010.125",
      "doi-asserted-by": "publisher",
      "key": "705_CR31",
      "unstructured": "Madadi P, Joly Y, Avard D, Chitayat DC, Smith MA, Ross CJD, ... Koren G (2010) Communicating pharmacogenetic research results to breastfeeding mothers taking codeine: A pilot study of perceptions and benefits. Clin Pharmacol Therapeutics 88(6):792–795. https://doi.org/10.1038/clpt.2010.125"
    },
    {
      "DOI": "10.1176/ps.2009.60.9.1167",
      "author": "TL Mark",
      "doi-asserted-by": "publisher",
      "first-page": "1167",
      "issue": "9",
      "journal-title": "Psychiatr Serv",
      "key": "705_CR32",
      "unstructured": "Mark TL, Levit KR, Buck JA (2009) Datapoints: Psychotropic drug prescriptions by medical specialty. Psychiatr Serv 60(9):1167–1167. https://doi.org/10.1176/ps.2009.60.9.1167",
      "volume": "60",
      "year": "2009"
    },
    {
      "DOI": "10.1002/cpt.2122",
      "author": "G McInnes",
      "doi-asserted-by": "publisher",
      "first-page": "1528",
      "issue": "6",
      "journal-title": "Clin Pharmacol Therapeutics",
      "key": "705_CR33",
      "unstructured": "McInnes G, Lavertu A, Sangkuhl K, Klein TE, Whirl-Carrillo M, Altman RB (2021) Pharmacogenetics at scale: An analysis of the UK Biobank. Clin Pharmacol Therapeutics 109(6):1528–1537. https://doi.org/10.1002/cpt.2122",
      "volume": "109",
      "year": "2021"
    },
    {
      "DOI": "10.1038/nrg1428",
      "author": "UA Meyer",
      "doi-asserted-by": "publisher",
      "first-page": "669",
      "issue": "9",
      "journal-title": "Nat Rev Genet",
      "key": "705_CR34",
      "unstructured": "Meyer UA (2004) Pharmacogenetics – five decades of therapeutic lessons from genetic diversity. Nat Rev Genet 5(9):669–676. https://doi.org/10.1038/nrg1428",
      "volume": "5",
      "year": "2004"
    },
    {
      "DOI": "10.1001/jama.1957.72980250010016",
      "author": "AG Motulsky",
      "doi-asserted-by": "publisher",
      "first-page": "835",
      "issue": "7",
      "journal-title": "J Am Med Assoc",
      "key": "705_CR35",
      "unstructured": "Motulsky AG (1957) Drug reactions, enzymes, and biochemical genetics. J Am Med Assoc 165(7):835–837. https://doi.org/10.1001/jama.1957.72980250010016",
      "volume": "165",
      "year": "1957"
    },
    {
      "DOI": "10.1038/s41525-018-0065-4",
      "author": "G Mukerjee",
      "doi-asserted-by": "publisher",
      "first-page": "26",
      "issue": "1",
      "journal-title": "Genomic Med",
      "key": "705_CR36",
      "unstructured": "Mukerjee G, Huston A, Kabakchiev B, Piquette-Miller M, van Schaik R, Dorfman R (2018) User considerations in assessing pharmacogenomic tests and their clinical support tools. Genomic Med 3(1):26. https://doi.org/10.1038/s41525-018-0065-4",
      "volume": "3",
      "year": "2018"
    },
    {
      "key": "705_CR37",
      "unstructured": "NICE (2022) NICE health technology evaluations: the manual. https://www.nice.org.uk/process/pmg36/chapter/introduction-to-health-technology-evaluation. Accessed Jan 2024"
    },
    {
      "DOI": "10.1097/ACM.0000000000000388",
      "doi-asserted-by": "crossref",
      "key": "705_CR38",
      "unstructured": "O’Brien BC, Harris IB, Beckman TJ, Reed DA, Cook DA (2014) Standards for reporting qualitative research: a synthesis of recommendations. Academic Medicine 89(9). https://journals.lww.com/academicmedicine/Fulltext/2014/09000/Standards_for_Reporting_Qualitative_Research__A.21.aspx"
    },
    {
      "key": "705_CR39",
      "unstructured": "O'Connor EA, Whitlock EP, Gaynes B, Beil TL (2009) U.S. preventive services task force evidence syntheses, formerly systematic evidence reviews. In Screening for depression in adults and older adults in primary care: an updated systematic review. Agency for Healthcare Research and Quality (US)"
    },
    {
      "key": "705_CR40",
      "unstructured": "Ontario Health (2021) Multi-gene pharmacogenomic testing that includes decision-support tools to guide medication selection for major depression: a health technology assessment (Ontario Technology Assessment Series, Issue. https://www.hqontario.ca/evidence-to-improve-care/health-technology-assessment/reviews-and-recommendations/multi-gene-pharmacogenomic-testing-that-includes-decision-support-tools-to-guide-medication-selection-for-major-depression. Accessed Jan 2024"
    },
    {
      "key": "705_CR41",
      "unstructured": "Ontario Health (2023) Health technology assessments methods and process guide. https://www.hqontario.ca/Portals/0/documents/evidence/reports/hta-methods-and-process-guide-en.pdf. Accessed Jan 2024"
    },
    {
      "DOI": "10.1001/jama.2022.9805",
      "doi-asserted-by": "publisher",
      "key": "705_CR42",
      "unstructured": "Oslin DW, Lynch KG, Shih M-C, Ingram EP, Wray LO, Chapman SR, ... Group PCR (2022) Effect of pharmacogenomic testing for drug-gene interactions on medication selection and remission of symptoms in major depressive disorder: The PRIME Care Randomized Clinical Trial. JAMA 328(2): 151-161https://doi.org/10.1001/jama.2022.9805"
    },
    {
      "DOI": "10.1111/cts.12986",
      "doi-asserted-by": "publisher",
      "key": "705_CR43",
      "unstructured": "Papastergiou J, Quilty LC, Li W, Thiruchselvam T, Jain E, Gove P, ... Pojskic N (2020) Pharmacogenomics guided versus standard antidepressant treatment in a community pharmacy setting: A randomized controlled trial. Clin Transl Sci 14(4): 1359–1368. https://doi.org/10.1111/cts.12986"
    },
    {
      "key": "705_CR44",
      "unstructured": "PharmGKB (2022) PharmGKB. https://www.pharmgkb.org/. Accessed Jan 2024"
    },
    {
      "key": "705_CR45",
      "unstructured": "QRS International (2022) NVivo. https://www.qsrinternational.com/nvivo-qualitative-data-analysis-software/home"
    },
    {
      "DOI": "10.3389/fgene.2020.00010",
      "author": "T Rigter",
      "doi-asserted-by": "publisher",
      "first-page": "10",
      "journal-title": "Front Genet",
      "key": "705_CR46",
      "unstructured": "Rigter T, Jansen ME, de Groot JM, Janssen SWJ, Rodenburg W, Cornel MC (2020) Implementation of pharmacogenetics in primary care: A multi-stakeholder perspective. Front Genet 11:10. https://doi.org/10.3389/fgene.2020.00010",
      "volume": "11",
      "year": "2020"
    },
    {
      "key": "705_CR47",
      "unstructured": "Rogers EM (2003) Diffusion of Innovations, 5th Edition. Free Press. https://books.google.ca/books?id=9U1K5LjUOwEC"
    },
    {
      "DOI": "10.1176/ajp.2006.163.11.1905",
      "doi-asserted-by": "publisher",
      "key": "705_CR48",
      "unstructured": "Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, ... Fava M (2006) Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. American Journal of Psychiatry 163(11): 1905–1917. https://doi.org/10.1176/ajp.2006.163.11.1905"
    },
    {
      "DOI": "10.1002/1098-240x(200008)23:4\u003c334::aid-nur9\u003e3.0.co;2-g",
      "author": "M Sandelowski",
      "doi-asserted-by": "publisher",
      "first-page": "334",
      "issue": "4",
      "journal-title": "Res Nurs Health",
      "key": "705_CR49",
      "unstructured": "Sandelowski M (2000) Whatever happened to qualitative description? Res Nurs Health 23(4):334–340. https://doi.org/10.1002/1098-240x(200008)23:4%3c334::aid-nur9%3e3.0.co;2-g",
      "volume": "23",
      "year": "2000"
    },
    {
      "DOI": "10.2105/ajph.2013.301596",
      "author": "JL Shaw",
      "doi-asserted-by": "publisher",
      "first-page": "2220",
      "issue": "12",
      "journal-title": "Am J Public Health",
      "key": "705_CR50",
      "unstructured": "Shaw JL, Robinson R, Starks H, Burke W, Dillard DA (2013) Risk, reward, and the double-edged sword: perspectives on pharmacogenetic research and clinical testing among Alaska Native people. Am J Public Health 103(12):2220–2225. https://doi.org/10.2105/ajph.2013.301596",
      "volume": "103",
      "year": "2013"
    },
    {
      "DOI": "10.1177/07067437221140383",
      "doi-asserted-by": "publisher",
      "key": "705_CR51",
      "unstructured": "Slomp C, Morris E, Edwards L, Hoens AM, Landry G, Riches L, ... Austin J (2022) Pharmacogenomic testing for major depression: A qualitative study of the perceptions of people with lived experience and professional stakeholders. Can J Psychiatry. https://doi.org/10.1177/07067437221140383"
    },
    {
      "DOI": "10.25318/9810002001-eng",
      "doi-asserted-by": "publisher",
      "key": "705_CR52",
      "unstructured": "Statistics Canada (2021a) Table 98–10–0020–01: age (in single years), average age and median age and gender: Canada, provinces and territories, census metropolitan areas and census agglomerations with parts. https://doi.org/10.25318/9810002001-eng. Accessed Jan 2024"
    },
    {
      "DOI": "10.25318/9810035101-eng",
      "doi-asserted-by": "publisher",
      "key": "705_CR53",
      "unstructured": "Statistics Canada (2021b) Table 98–10–0351–01: visible minority by gender and age: Canada, provinces and territories. https://doi.org/10.25318/9810035101-eng. Accessed Jan 2024"
    },
    {
      "DOI": "10.25318/9810048101-eng",
      "doi-asserted-by": "publisher",
      "key": "705_CR54",
      "unstructured": "Statistics Canada (2021c) Table 98–10–0481–01: place of work status by highest level of education and gender: Canada, provinces and territories, census divisions and census subdivisions. https://doi.org/10.25318/9810048101-eng. Accessed Jan 2024"
    },
    {
      "DOI": "10.1111/cts.13083",
      "author": "M Subasri",
      "doi-asserted-by": "publisher",
      "first-page": "2231",
      "issue": "6",
      "journal-title": "Clin Transl Sci",
      "key": "705_CR55",
      "unstructured": "Subasri M, Barrett D, Sibalija J, Bitacola L, Kim RB (2021) Pharmacogenomic-based personalized medicine: Multistakeholder perspectives on implementational drivers and barriers in the Canadian healthcare system. Clin Transl Sci 14(6):2231–2241. https://doi.org/10.1111/cts.13083",
      "volume": "14",
      "year": "2021"
    },
    {
      "DOI": "10.1016/s0140-6736(22)01841-4",
      "doi-asserted-by": "publisher",
      "key": "705_CR56",
      "unstructured": "Swen JJ, van der Wouden CH, Manson LE, Abdullah-Koolmees H, Blagec K, Blagus T, ... Guchelaar HJ (2023) A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study. Lancet 401(10374): 347–356. https://doi.org/10.1016/s0140-6736(22)01841-4"
    },
    {
      "DOI": "10.7812/tpp/15-046",
      "author": "SB Trinidad",
      "doi-asserted-by": "publisher",
      "first-page": "21",
      "issue": "3",
      "journal-title": "Perm J",
      "key": "705_CR57",
      "unstructured": "Trinidad SB, Coffin TB, Fullerton SM, Ralston J, Jarvik GP, Larson EB (2015) “Getting off the Bus Closer to Your Destination”: Patients’ views about pharmacogenetic testing. Perm J 19(3):21–27. https://doi.org/10.7812/tpp/15-046",
      "volume": "19",
      "year": "2015"
    },
    {
      "DOI": "10.1016/S1701-2163(15)30568-5",
      "author": "M Vanstone",
      "doi-asserted-by": "publisher",
      "first-page": "515",
      "issue": "6",
      "journal-title": "J Obstet Gynaecol Can",
      "key": "705_CR58",
      "unstructured": "Vanstone M, King C, de Vrijer B, Nisker J (2014) Non-invasive prenatal testing: ethics and policy considerations. J Obstet Gynaecol Can 36(6):515–526. https://doi.org/10.1016/S1701-2163(15)30568-5",
      "volume": "36",
      "year": "2014"
    },
    {
      "DOI": "10.1177/1049732315589745",
      "author": "M Vanstone",
      "doi-asserted-by": "publisher",
      "first-page": "1069",
      "issue": "8",
      "journal-title": "Qual Health Res",
      "key": "705_CR59",
      "unstructured": "Vanstone M, Yacoub K, Giacomini M, Hulan D, McDonald S (2015) Women’s experiences of publicly funded non-invasive prenatal testing in Ontario, Canada: Considerations for health technology policy-making. Qual Health Res 25(8):1069–1084. https://doi.org/10.1177/1049732315589745",
      "volume": "25",
      "year": "2015"
    },
    {
      "author": "M Vanstone",
      "first-page": "1",
      "issue": "5",
      "journal-title": "Ont Health Technol Assess Ser",
      "key": "705_CR60",
      "unstructured": "Vanstone M, Cernat A, Majid U, Trivedi F, De Freitas C (2019) Perspectives of pregnant people and clinicians on noninvasive prenatal testing: A systematic review and qualitative meta-synthesis. Ont Health Technol Assess Ser 19(5):1–38",
      "volume": "19",
      "year": "2019"
    }
  ],
  "reference-count": 60,
  "references-count": 60,
  "resource": {
    "primary": {
      "URL": "https://link.springer.com/10.1007/s12687-024-00705-y"
    }
  },
  "score": 0,
  "short-container-title": [
    "J Community Genet"
  ],
  "source": "Crossref",
  "title": [
    "Patient perspectives on pharmacogenomic (PGx) testing for antidepressant prescribing in primary care: a qualitative description study"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy"
}